Results 11 to 20 of about 67,088,256 (273)

IL-33 and IL-33-derived DC-based tumor immunotherapy

open access: yesExperimental and Molecular Medicine
Interleukin-33 (IL-33), a member of the IL-1 family, is a cytokine released in response to tissue damage and is recognized as an alarmin. The multifaceted roles of IL-33 in tumor progression have sparked controversy within the scientific community ...
Myeong-Ho Kang, Yong-Soo Bae
doaj   +4 more sources

IL-33 in Rheumatic Diseases [PDF]

open access: yesFrontiers in Medicine, 2021
Interleukin-33 (IL-33) is a nuclear factor mainly expressed in barrier epithelium, endothelial cells, and fibroblast reticular cells. Some inflammatory cells also express IL-33 under certain conditions.
Yuanji Dong, Jixin Zhong, Lingli Dong
doaj   +3 more sources

IL-33 in Mental Disorders [PDF]

open access: yesMedicina, 2021
Mental disorders are common in the general population; every year about 25% of the total European population is affected by a mental condition. The prevalence of psychiatric disorders might be underestimated.
Gianluca Pandolfo   +6 more
doaj   +4 more sources

IL-33 Raises Alarm [PDF]

open access: yesImmunity, 2009
The interleukin-1 (IL-1)-like cytokine IL-33 is widely assumed to undergo proteolytic maturation by caspase-1. In this issue of Immunity, Luthi et al. (2009) show that IL-33 is not a caspase-1 substrate.
Dixit, VM, Lamkanfi, Mohamed
core   +3 more sources

IL-33: a Janus cytokine

open access: yesAnnals of the Rheumatic Diseases, 2012
Interleukin (IL) 33, a member of the IL-1 family, is the ligand of ST2 that is expressed mainly on activated Th2 cells and mast cells. IL-33 can skew a predominantly Th1 cell population to a mainly Th2 cells phenotype in vivo.
Liew, F.Y.
core   +3 more sources

IL-33/IL-31 axis in osteoporosis [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
The study of the immunoskeletal interface has led to the discovery of numerous cytokines involved in the regulation of bone remodeling, providing valuable information on the pathogenesis of osteoporosis.
Mariano Suppa   +7 more
core   +5 more sources

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo [PDF]

open access: yes, 2014
Rationale: Rhinoviruses are the major cause of asthma exacerbations; however, its underlying mechanisms are poorly understood. We hypothesized that the epithelial cell–derived cytokine IL-33 plays a central role in exacerbation pathogenesis through ...
Maria-Belen Trujillo-Torralbo (4405423)   +31 more
core   +7 more sources

IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk.

open access: yes, 2015
BACKGROUND: Mast cell localization within the airway smooth muscle (ASM)-bundle plays an important role in the development of airway hyper-responsiveness (AHR).
E. Gomez (6708803)   +13 more
core   +6 more sources

IL-33 and Airway Inflammation [PDF]

open access: yesAllergy, Asthma and Immunology Research, 2011
Interleukin-33 (IL-33) is the 11th member of IL-1 cytokine family which includes IL-1 and IL-18. Unlike IL-1β and IL-18, IL-33 is suggested to function as an alarmin that is released upon endothelial or epithelial cell damage and may not enhance acquired immune responses through activation of inflammasome.
Oboki, Keisuke   +3 more
openaire   +2 more sources

Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy [PDF]

open access: yes, 2014
Helminth parasites such as the nematode Heligmosomoides polygyrus strongly inhibit T helper type 2 (Th2) allergy, as well as colitis and autoimmunity. Here, we show that the soluble excretory/secretory products of H.
McSorley, H. J.; id_orcid   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy